Previous 10 | Next 10 |
The bloodbath for Cathie Wood’s ARK Innovation ETF (NYSEARCA:ARKK) continues, despite the fund being up slightly on Thursday. Wood’s ETF is -36% YTD and is currently working towards its fifth straight downward month. Meanwhile, this week has been particularly difficult...
The Ark Innovation ETF was fallen 60% from its high water mark, far more than 10%ish drop of the handful of growth stocks which top the S&P 500 and NASDAQ100. Charts and tables for price and AUM show clearly the the majority of investors in ARKK bought at the top; most ARKK holder...
The Business Intelligence Group today announced that it has awarded Abveris , a division of Twist Bioscience , a Best Places to Work 2022. The organization sought to identify companies that are actively working to improve their own performance through efforts to challenge em...
Twist Biosciences (NASDAQ:TWST) will collaborate with Kriya Therapeutics to discover antibodies delivered using adeno-associated viral gene therapy for oncology applications. Twist (TWST) has an antibody discovery and optimization platform to discover antibodies against specific targets ...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Kriya Therapeutics , Inc., a fully integrated company pioneering novel technologies and therapeutics in...
The following slide deck was published by Twist Bioscience Corporation in conjunction with this event. For further details see: Twist Bioscience Corp (TWST) Investor Presentation - Slideshow
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it has become a part of the Digital Preservation Coalition’s (DPC) Supporter Program, where memb...
The following slide deck was published by Twist Bioscience Corporation in conjunction with their 2022 Q1 earnings call. For further details see: Twist Bioscience Corporation 2022 Q1 - Results - Earnings Call Presentation
Twist Bioscience (NASDAQ:TWST) has priced an upsized, underwritten public offering of 4,545,454 shares of its common stock at a price to the public of $55.00/share for an expected gross proceeds of ~$250M. Underwriters are granted a 30-day option to purchase up to an additional 681,818 shares...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the pricing of an upsized, underwritten public offering of 4,545,454 shares of its common stock at a price ...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...